Panteghini M, Pagani F
Laboratorio Analisi Chimico-Cliniche, Spedali Civili, Brescia, Italy.
J Clin Chem Clin Biochem. 1988 May;26(5):277-80.
Serum creatinine kinase MB isoenzyme time-activity curves are useful for the assessment of coronary reperfusion after acute myocardial infarction. The purpose of this study was to compare serum creatine kinase MB catalytic activity with mass concentration for the determination of coronary reflow after therapeutic thrombolysis. Creatine kinase MB mass was determined immunoenzymometrically. Creatinine kinase MB catalytic activity concentration was determined by electrophoresis. Serum was collected every 4 hours for 96 hours in two groups of myocardial infarction patients: A (n = 10), urokinase induced reperfusion; B (n = 10), conventional therapy without urokinase. Peaks of mass and activity occurred at similar times in groups A and B. Both were significantly earlier in the urokinase treated patients. The maximal rate of increase of creatine kinase MB (based on either mass or catalytic activity) was threefold greater in the urokinase group. There are no important differences between the behaviour of creatine kinase measured as catalytic concentration or as mass concentration. Mass concentration is therefore equally useful as an indicator of coronary reperfusion.
血清肌酸激酶MB同工酶时间-活性曲线对于评估急性心肌梗死后的冠状动脉再灌注很有用。本研究的目的是比较血清肌酸激酶MB的催化活性和质量浓度,以确定治疗性溶栓后的冠状动脉再通情况。采用免疫酶法测定肌酸激酶MB质量。通过电泳法测定肌酐激酶MB催化活性浓度。在两组心肌梗死患者中,每4小时采集一次血清,共采集96小时:A组(n = 10),尿激酶诱导再灌注;B组(n = 10),未使用尿激酶的传统治疗。A组和B组中质量和活性的峰值出现在相似的时间。在接受尿激酶治疗的患者中,两者出现的时间明显更早。尿激酶组中肌酸激酶MB(基于质量或催化活性)的最大增加速率高出三倍。以催化浓度或质量浓度测定的肌酸激酶行为之间没有重要差异。因此,质量浓度作为冠状动脉再灌注的指标同样有用。